Jakafi 10 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FDJM6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,663
Award facts
- Contract value 100% obligated
- $12,663.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,663.27 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg. The delivery order, issued on January 15, 2026, with an ultimate completion date of January 16, 2026, carries no set-aside designation, indicating the award was made through open competition. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and serves as the sole contractor on this engagement with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded in November 2025 with a $499.999 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents a strategic $30.3 billion acquisition vehicle designed to establish multiple regional prime vendor contractors supplying comprehensive pharmaceutical products—including branded and generic prescription drugs, biologics, and medical consumables—to support Department of Defense military healthcare facilities worldwide. The contractor's established performance across numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FDJM6?
SPE2DR26FDJM6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FDJM6 worth?
The government has obligated $12,663 on SPE2DR26FDJM6.
Is contract SPE2DR26FDJM6 an order under another contract?
Yes. SPE2DR26FDJM6 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJM6 competed?
The extent of competition for SPE2DR26FDJM6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award